antimycin a has been researched along with celastrol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Abu Bakar, MH; Cheng, KK; Huri, HZ; Sarmidi, MR; Yaakob, H | 1 |
2 other study(ies) available for antimycin a and celastrol
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Celastrol Protects against Antimycin A-Induced Insulin Resistance in Human Skeletal Muscle Cells.
Topics: Antimycin A; Cell Line; Glucose; Glucose Transporter Type 4; Humans; Inflammation; Insulin; Insulin Resistance; Mitochondria; Muscle Cells; Muscle, Skeletal; NF-kappa B; Pentacyclic Triterpenes; Phosphatidylinositol 3-Kinases; Phosphorylation; Protective Agents; Protein Kinase C; Proto-Oncogene Proteins c-akt; Signal Transduction; Triterpenes | 2015 |